THE EFFECT OF TRIACETYL AZAURIDINE ON PSORIASIS.
D000740:Anemia; D001380:Azauridine / Q000031:analogs & derivatives; D004358:Drug Therapy; D006413:Hematopoietic System; D006801:Humans; D009182:Mycosis Fungoides; D009705:Nucleosides; D010336:Pathology; D011506:Proteins / Q000378:metabolism*; D011565:Psoriasis; D011743:Pyrimidines; D014116:Toxicology
D009705:Nucleosides; D011506:Proteins; D011743:Pyrimidines; D001380:Azauridine; C100231:azaribine
ANEMIA; DRUG THERAPY; HEMATOPOIETIC SYSTEM; MYCOSIS FUNGOIDES; NUCLEOSIDES; PATHOLOGY; PROTEIN METABOLISM; PSORIASIS; PYRIMIDINES; TOXICOLOGIC REPORT